Title of article
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-B
Author/Authors
Bjorn Dahlof، نويسنده , , Peter S. Sever، نويسنده , , Neil R. Poulter، نويسنده , , Hans Wedel، نويسنده , , D. Gareth Beevers، نويسنده , , Mark Caulfield، نويسنده , , Rory Collins، نويسنده , , Sverre E Kjeldsen، نويسنده , , Arni Kristinsson، نويسنده , , Gordon T. McInnes، نويسنده , , Jesper Mehlsen، نويسنده , , Markku Nieminen، نويسنده , , Eoin OʹBrien، نويسنده , , Jan ostergren، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
12
From page
895
To page
906
Abstract
Background
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics and β blockers used. For a given reduction in blood pressure, some suggested that newe
Journal title
The Lancet
Serial Year
2006
Journal title
The Lancet
Record number
588643
Link To Document